Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.

about

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome.

Item

http://www.wikidata.org/entity/Q49666836

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Antithrombotic efficacy of biv ...... n for acute coronary syndrome.

@en

Antithrombotic efficacy of biv ...... n for acute coronary syndrome.

@nl

type

Item

label

Antithrombotic efficacy of biv ...... n for acute coronary syndrome.

@en

Antithrombotic efficacy of biv ...... n for acute coronary syndrome.

@nl

prefLabel

Antithrombotic efficacy of biv ...... n for acute coronary syndrome.

@en

Antithrombotic efficacy of biv ...... n for acute coronary syndrome.

@nl

P1476

Antithrombotic efficacy of biv ...... on for acute coronary syndrome

@en

P2093

Corinne Frere

http://www.w3.org/2001/XMLSchema#string

Franck Paganelli

http://www.w3.org/2001/XMLSchema#string

Laurence Camoin-Jau

http://www.w3.org/2001/XMLSchema#string

Laurent Bonello

http://www.w3.org/2001/XMLSchema#string

Noemie Resseguier

http://www.w3.org/2001/XMLSchema#string

Pierre-Emmanuel Morange

http://www.w3.org/2001/XMLSchema#string

Regis Guieu

http://www.w3.org/2001/XMLSchema#string

P2860

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition

Bivalirudin during primary PCI in acute myocardial infarction

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Composition of coronary thrombus in acute myocardial infarction.

Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.

Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary intervention.

P304

105-111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09537104.2017.1384541

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

G Lemesle

Marc Laine

Françoise Dignat-George

P577

2017-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29172822

http://www.w3.org/2001/XMLSchema#string